November 30, 2021
Life Sciences
  • Pfizer is planning to ask the Food and Drug Administration to approve its COVID-19 booster for 16- and 17-year-olds. According to sources, the agency could authorize extra shots within roughly a week. The request comes as President Biden seeks to reassure the nation about the new Omicron variant, which he called “a cause for concern, not a cause for panic.” (Articles here, here, here, and here)